Gene Therapy Prolongs Survival and Restores Function in Murine and Canine Models of Myotubular MyopathyMartin K. Childers, Anna Buj‐Bello, Michael W. Lawlor et al.|Science Translational Medicine|2014Cited by 170
Safety and efficacy of gene replacement therapy for X-linked myotubular myopathy (ASPIRO): a multinational, open-label, dose-escalation trialPerry B. Shieh, Salvador Rico, Nancy L. Kuntz et al.|The Lancet Neurology|2023Cited by 120
Systemic AAV8-Mediated Gene Therapy Drives Whole-Body Correction of Myotubular Myopathy in DogsDavid L. Mack, Martin K. Childers, Karine Poulard et al.|Molecular Therapy|2017Cited by 109